14-day Premium Trial Subscription Try For FreeTry Free
$11.65
-0.110 (-0.94%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 DVAX stock ended at $11.65. This is 0.94% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 1.76% from a day low at $11.64 to a day high of $11.85.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Dec 30, 2016 $4.05 $4.10 $3.90 $3.95 1 073 553
Dec 29, 2016 $3.95 $4.15 $3.90 $4.10 1 464 625
Dec 28, 2016 $4.05 $4.20 $3.95 $3.95 643 377
Dec 27, 2016 $4.10 $4.20 $4.01 $4.10 908 483
Dec 23, 2016 $4.05 $4.20 $4.00 $4.10 1 128 790
Dec 22, 2016 $4.15 $4.25 $4.05 $4.05 884 206
Dec 21, 2016 $4.20 $4.38 $4.10 $4.15 702 179
Dec 20, 2016 $4.45 $4.60 $4.15 $4.20 1 225 918
Dec 19, 2016 $4.45 $4.70 $4.30 $4.40 2 331 412
Dec 16, 2016 $4.10 $4.50 $4.05 $4.40 3 049 795
Dec 15, 2016 $3.90 $4.10 $3.80 $4.10 1 628 091
Dec 14, 2016 $4.15 $4.20 $3.90 $3.90 1 035 834
Dec 13, 2016 $4.55 $4.55 $4.00 $4.10 2 293 563
Dec 12, 2016 $4.60 $4.75 $4.45 $4.45 1 577 034
Dec 09, 2016 $4.80 $5.00 $4.60 $4.65 1 920 300
Dec 08, 2016 $5.00 $5.20 $4.80 $4.80 2 386 122
Dec 07, 2016 $5.10 $5.15 $4.75 $5.00 2 116 325
Dec 06, 2016 $5.10 $5.40 $4.85 $5.20 2 086 347
Dec 05, 2016 $4.75 $5.18 $4.75 $5.15 2 021 334
Dec 02, 2016 $4.35 $4.80 $4.25 $4.70 1 483 257
Dec 01, 2016 $4.40 $4.50 $4.15 $4.35 1 466 585
Nov 30, 2016 $4.80 $4.90 $4.30 $4.30 2 134 324
Nov 29, 2016 $4.60 $4.90 $4.55 $4.75 1 262 735
Nov 28, 2016 $4.90 $5.00 $4.55 $4.60 1 623 541
Nov 25, 2016 $4.90 $5.00 $4.80 $5.00 658 110
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
BBCA May 03 0.99% $65.44
INVH May 03 0.90% $34.39
BNDX May 03 0.247% $48.68
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT